Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs

被引:57
作者
Leather, HA [1 ]
Eycken, KV
Segers, P
Herijgers, P
Vandermeersch, E
Wouters, PF
机构
[1] Katholieke Univ Leuven, Ctr Expt Surg & Anesthesiol, Dept Anesthesiol, Louvain, Belgium
[2] Katholieke Univ Leuven, Dept Cardiac Surg, Louvain, Belgium
[3] State Univ Ghent, Inst Biomed Technol, Hydraul Lab, B-9000 Ghent, Belgium
关键词
inotropic agents; calcium sensitizers; levosimendan; ventricular function; pulmonary vasculature; pig;
D O I
10.1097/01.CCM.0000084844.95073.C0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Levosimendan is a promising calcium sensitizer that potentially could be useful in settings of pulmonary vasoconstriction and right ventricular dysfunction. There is a shortage of information concerning its effects on right ventricular function and ventriculovascular coupling. The aim of the present study was to characterize the effects of levosimendan on right ventricular and pulmonary vascular function by means of pressure-volume and pulsatile flow analysis. Design: Prospective laboratory investigation. Setting. University hospital laboratory Subjects: Eight landrace pigs (mean weight, 37 kg). Interventions. Following instrumentation with biventricular conductance catheters, pulmonary and right coronary artery flow probes, a high-fidelity pulmonary pressure catheter, and a right coronary venous catheter, hemodynamic measurements were performed in baseline conditions and during levosimendan infusion at three increasing plasma concentrations (mean values, 27.5, 67.6, and 142.5 ng/mL). Measurements and Main Results: Levosimendan increased heart rate and cardiac output, reduced systemic vascular resistance, and had a positive inotropic effect on the left ventricle and increased left ventricular mechanical efficiency. Moreover, levosimendan increased right ventricular contractility and hydraulic power. However, total pulmonary vascular resistance and characteristic impedance did not change throughout the protocol, and right ventricular mechanical efficiency decreased slightly at the highest concentration of levosimendan. Conclusions. At clinical concentrations in the present model, levosimendan increases right ventricular contractility and performance without significantly influencing pulmonary vascular tone. Further studies are required in a model of pulmonary vasoconstriction to disclose possible pulmonary vasodilator effects of levosimendan.
引用
收藏
页码:2339 / 2343
页数:5
相关论文
共 28 条
  • [1] CONTINUOUS MEASUREMENT OF LEFT-VENTRICULAR VOLUME IN ANIMALS AND HUMANS BY CONDUCTANCE CATHETER
    BAAN, J
    VANDERVELDE, ET
    DEBRUIN, HG
    SMEENK, GJ
    KOOPS, J
    VANDIJK, AD
    TEMMERMAN, D
    SENDEN, J
    BUIS, B
    [J]. CIRCULATION, 1984, 70 (05) : 812 - 823
  • [2] De Witt BJ, 2002, ANESTH ANALG, V94, P1427
  • [3] Du Toit EF, 1999, J PHARMACOL EXP THER, V290, P505
  • [4] Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
    Follath, F
    Cleland, JGF
    Just, H
    Papp, JGY
    Scholz, H
    Peuhkurinen, K
    Harjola, VP
    Mitrovic, V
    Abdalla, M
    Sandell, EP
    Lehtonen, L
    [J]. LANCET, 2002, 360 (9328) : 196 - 202
  • [5] Gavazzi A, 1997, J HEART LUNG TRANSPL, V16, P774
  • [6] Right ventricular dysfunction persists following brief right ventricular pressure overload
    Greyson, C
    Xu, Y
    Cohen, J
    Schwartz, GG
    [J]. CARDIOVASCULAR RESEARCH, 1997, 34 (02) : 281 - 288
  • [7] TROPONIN C-MEDIATED CALCIUM SENSITIZATION INDUCED BY LEVOSIMENDAN DOES NOT IMPAIR RELAXATION
    HAIKALA, H
    NISSINEN, E
    ETEMADZADEH, E
    LEVIJOKI, J
    LINDEN, IB
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (05) : 794 - 801
  • [8] The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan
    Haikala, H
    Kaheinen, P
    Levijoki, J
    Linden, IB
    [J]. CARDIOVASCULAR RESEARCH, 1997, 34 (03) : 536 - 546
  • [9] Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of KATP channels
    Kersten, JR
    Montgomery, MW
    Pagel, PS
    Warltier, DC
    [J]. ANESTHESIA AND ANALGESIA, 2000, 90 (01) : 5 - 11
  • [10] Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure
    Kivikko, M
    Antila, S
    Eha, J
    Lehtonen, L
    Pentikäinen, PJ
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (01) : 43 - 51